About Forkhead box protein N2
Forkhead box protein N2 (FOXN2) is a protein
from Homo sapiens identified by UniProt accession
P32314, 431 residues long.
MolForge cross-references it against 0 known binders and
74 disease associations.
Target properties
| Protein name | Forkhead box protein N2 |
| UniProt accession | P32314 |
| Gene | FOXN2 |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (74)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.43
- sex hormone-binding globulin measurement · score 0.40
- vital capacity · score 0.40
- serum alanine aminotransferase measurement · score 0.37
- HbA1c measurement · score 0.37
- serum gamma-glutamyl transferase measurement · score 0.36
- body height · score 0.36
- mathematical ability · score 0.35
- alkaline phosphatase measurement · score 0.33
- body fat percentage · score 0.33
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P32314-F1 | alphafold | PREDICTED | 60.33 | — |
Amino-acid sequence (431 residues)
MGPVIGMTPD KRAETPGAEK IAGLSQIYKM GSLPEAVDAA RPKATLVDSE SADDELTNLN WLHESTNLLT NFSLGSEGLP IVSPLYDIEG DDVPSFGPAC YQNPEKKSAT SKPPYSFSLL IYMAIEHSPN KCLPVKEIYS WILDHFPYFA TAPTGWKNSV RHNLSLNKCF QKVERSHGKV NGKGSLWCVD PEYKPNLIQA LKKQPFSSAS SQNGSLSPHY LSSVIKQNQV RNLKESDIDA AAAMMLLNTS IEQGILECEK PLPLKTALQK KRSYGNAFHH PSAVRLQESD SLATSIDPKE DHNYSASSMA AQRCASRSSV SSLSSVDEVY EFIPKNSHVG SDGSEGFHSE EDTDVDYEDD PLGDSGYASQ PCAKISEKGQ SGKKMRKQTC QEIDEELKEA AGSLLHLAGI RTCLGSLIST AKTQNQKQRK K
Explore Forkhead box protein N2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets